Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asfotase alfa
asfotase alfa
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
Alexion CEO Receives Nearly $17 Million for Sale of Company Stock
Yahoo/Gurufocus
Fri, 08/15/14 - 05:22 am
Alexion
Pharma CEOs
asfotase alfa
Alexion reports data from Phase 2 study of asfotase alfa
Yahoo/Fly on the Wall
Mon, 09/23/13 - 09:39 am
Alexion
asfotase alfa
hypophosphatasia
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Alexion snags latest 'breakthrough' coup with PhIII rare-disease drug
Fierce Biotech
Tue, 05/28/13 - 08:25 am
Alexion
asfotase alfa
hypophosphatasia